Inmunotek S.L.
Pre-Approval PRO BETASlowing Activity
No new clinical trials started in 1-2 years. Monitor for changes in pipeline strategy. Last trial started: 4/2/2025
Pipeline by Phase
Therapeutic Focus
Clinical Trials (12)
Efficacy and Safety of SLIT in Patients With Rhinitis/RC With/Without Mild-moderate Asthma, Due to Dpt and/or Df
Started: 4/2/2025
Efficacy and Safety Evaluation for the Treatment of Allergy Against Mites
Started: 10/6/2020
Efficacy and Safety Evaluation of the Treatment of Allergy Against Cupressaceae and Grasses.
Started: 5/31/2021
Efficacy and Safety Evaluation for the Treatment of Allergy Against Grass and Olive Pollen
Started: 6/14/2021
Efficacy and Safety Evaluation for the Treatment of Asthma and Allergic Rhinitis/Rhinoconjunctivitis
Started: 4/30/2021
Efficacy and Safety Evaluation in Recurrent Wheezing Attacks
Started: 10/1/2012
Efficacy of BACMUNE (MV130) in the Prevention of Disease Due to COVID-19 Infection in Healthcare Personnel
Started: 10/1/2020
Evaluation of the Efficacy and Safety of MV130 in Chronic Obstructive Pulmonary Disease (COPD)
Started: 5/6/2013
Clinical Trial to Evaluate the Efficacy and Safety of Polymerized, Mannan-Conjugated Dermatophagoides Allergen Extract
Started: 11/1/2023
Determination of the Sensitivity and Specificity of Prick Test Betula Verrucosa
Started: 9/1/2015
Dose Finding for the Treatment of Rhinitis/Rhinoconjunctivitis Against Grass Pollen Allergy
Started: 12/30/2015